Revelation Biosciences Inc (REVB)

Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	18.22% 1.9021	2.3259	2.7779	1.933	1.6198
Operating Income/Loss	18.22% -1.9021	-2.3259	-2.7779	-1.933	-1.6198
Nonoperating Income/Loss	733.64% -0.7793	0.123	0.1495	0.4849	7.779
Income/Loss From Continuing Operations Before Tax	21.72% -2.6814	-2.2029	-2.6284	-1.4482	6.1592
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	21.72% -2.6814	-2.2029	-2.6284	-1.4482	6.1592
Net Income/Loss	21.72% -2.6814	-2.2029	-2.6284	-1.4482	6.1592
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	123.54% 1.0898	-4.629	6.2973	5.8123	2.2107
Diluted Average Shares	122.73% 1.0898	-4.7955	6.2973	5.8123	3.1359
Basic Earnings Per Share	156.25% -2.46	-0.96	-0.42	-0.25	2.79
Diluted Earnings Per Share	161.70% -2.46	-0.94	-0.42	-0.25	1.96
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-